Popular

News
Topical BioMedics' Topricin Selected for Paul McCartney's MusiCares Tribute
San Francisco Chronicle (press release)
Topricin Pain Relief and Healing Cream has been selected to be featured during the silent auction at the MusiCares gala honoring Paul McCartnery during the 54th Annual Grammy Week festivities. Topical BioMedics is providing a "Remedies for Your
Vehicle Selection Is Key to Topically Treating Psoriasis
Skin and Allergy News Digital Network
Vehicle options for topical psoriasis therapy include cream, ointment, tape, gel, lotion, aerosol spray, foam, solution, shampoo, powder, and oil. There is no silver bullet when it comes to psoriasis, but topical therapy remains many dermatologists'
Nuvo Research announces launch of Synera® in the U.S.
MarketWatch (press release)
Pliaglis is a topical local anesthetic cream, which is US Food and Drug Administration (FDA) approved to provide topical local analgesia for superficial dermatological procedures.The Company has licensed worldwide marketing rights to Pliaglis to
New anti-wrinkle product competes with Botox
WWL
The new topical or rub on Botox type creams are not FDA approved yet but here's what doctors are telling us. In studies they seem to work best right here around the crows feet. That's because the skin there is thinner and they'll absorb better.
OnMilwaukee.com recommends, Feb. 4, 2012
OnMilwaukee.com
The biggest thrill and most unexpected result with this OTC topical after just two weeks of use? Spots of hyperpigmentation (red acne scars) that previously resisted prescription creams have started to dramatically lighten. I wore the super light,
Apricus premature ejaculation cream receives Israeli Patent NoA
Pharmaceutical Business Review
Apricus Biosciences has received a Notice of Allowance (NoA) from the Israeli Patent Office to grant a patent for the company's development of a topical cream utilizing vasoactive prostaglandin E to treat premature ejaculation (PE).
EpiCept Corporation Confirms Engagement of SunTrust Robinson Humphrey to
MarketWatch (press release)
Ferrer Beginning Phase 3 Trial
Drug Discovery & Development
Ozenoxacin is a novel second generation non-fluorinated quinolone antibacterial agent undergoing clinical development, formulated as a topical one per cent cream, for infectious dermatological conditions. In preclinical studies, the bactericidal action
Ferrer to begin antibacterial compound Phase III trials
Pharmaceutical Business Review
EpiCept Corporation Receives Finalized FDA Guidance for AmiKet(TM) Phase III
MarketWatch (press release)
AmiKet(TM) is a prescription topical cream intended for the treatment of peripheral neuropathic pain. In the final meeting minutes recently received by EpiCept, the FDA acknowledged that painful symptoms due to CIPN represent a significant unmet




